According to Novo Integrated Sciences's latest financial reports the company's current earnings (TTM) are -$14 M. In 2022 the company made an earning of -$35.19 M a decrease over its 2021 earnings that were of -$5.52 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$14 M | -60.23% |
2022 | -$35.19 M | 538.13% |
2021 | -$5.52 M | -1.68% |
2020 | -$5.61 M | 2276.88% |
2019 | -$0.24 M | -88.59% |
2018 | -$2.07 M | 135.65% |
2017 | -$0.88 M | 432.05% |
2016 | -$0.17 M | -94.02% |
2015 | -$2.76 M | 166.92% |
2014 | -$1.04 M | 16.43% |
2013 | -$0.89 M | -16.29% |
2012 | -$1.07 M | -52.62% |
2011 | -$2.24 M | -10.73% |
2010 | -$2.51 M | 26.6% |
2009 | -$1.99 M | 105.53% |
2008 | -$0.97 M | -61.24% |
2007 | -$2.49 M | 69.91% |
2006 | -$1.47 M | 37.02% |
2005 | -$1.07 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Select Medical Holdings SEM | $0.58 B | -4,251.92% | ๐บ๐ธ USA |
HealthSouth
EHC | $0.60 B | -4,439.19% | ๐บ๐ธ USA |
Novo Integrated Sciences NVOS | -$14 M | 0.00% | ๐บ๐ธ USA |